ABBV-295
A Study of ABBV-295 Subcutaneous Injections to Assess Pharmacokinetics and Adverse Events in Healthy Adult Women Participants With Overweight or Obesity Taking Oral Contraceptives
AbbVie · Phase 1 · Completed · Enrollment 20
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| ABBV-295 with Levonorgestrel and Ethinyl Estradiol | n/r | n/r | n/r | n/r |
Not shown
- ABBV-295 with Levonorgestrel and Ethinyl Estradiol: endpoint not reported